scholarly journals In Vivo Evidence for Impaired Glymphatic Function in the Visual Pathway of Patients With Normal Pressure Hydrocephalus

2020 ◽  
Vol 61 (13) ◽  
pp. 24
Author(s):  
Henrik Holvin Jacobsen ◽  
Tiril Sandell ◽  
Øystein Kalsnes Jørstad ◽  
Morten C. Moe ◽  
Geir Ringstad ◽  
...  
2010 ◽  
pp. n/a-n/a ◽  
Author(s):  
Kaspar-Josche Streitberger ◽  
Edzard Wiener ◽  
Jan Hoffmann ◽  
Florian Baptist Freimann ◽  
Dieter Klatt ◽  
...  

2021 ◽  
Vol 10 (8) ◽  
pp. 1711
Author(s):  
Afroditi Despina Lalou ◽  
Marek Czosnyka ◽  
Michal M. Placek ◽  
Peter Smielewski ◽  
Eva Nabbanja ◽  
...  

Background: Despite the quantitative information derived from testing of the CSF circulation, there is still no consensus on what the best approach could be in defining criteria for shunting and predicting response to CSF diversion in normal pressure hydrocephalus (NPH). Objective: We aimed to review the lessons learned from assessment of CSF dynamics in our center and summarize our findings to date. We have focused on reporting the objective perspective of CSF dynamics testing, without further inferences to individual patient management. Discussion: No single parameter from the CSF infusion study has so far been able to serve as an unquestionable outcome predictor. Resistance to CSF outflow (Rout) is an important biological marker of CSF circulation. It should not, however, be used as a single predictor for improvement after shunting. Testing of CSF dynamics provides information on hydrodynamic properties of the cerebrospinal compartment: the system which is being modified by a shunt. Our experience of nearly 30 years of studying CSF dynamics in patients requiring shunting and/or shunt revision, combined with all the recent progress made in producing evidence on the clinical utility of CSF dynamics, has led to reconsidering the relationship between CSF circulation testing and clinical improvement. Conclusions: Despite many open questions and limitations, testing of CSF dynamics provides unique perspectives for the clinician. We have found value in understanding shunt function and potentially shunt response through shunt testing in vivo. In the absence of infusion tests, further methods that provide a clear description of the pre and post-shunting CSF circulation, and potentially cerebral blood flow, should be developed and adapted to the bed-space.


2021 ◽  
Vol 17 (S5) ◽  
Author(s):  
Antti J. Luikku ◽  
Tuomas Rauramaa ◽  
Ossi Nerg ◽  
Anne M. Koivisto ◽  
Antti Junkkari ◽  
...  

2021 ◽  
pp. 1-10
Author(s):  
Sylwia Libard ◽  
Jochen Walter ◽  
Irina Alafuzoff

Background: Stepwise occurrence of biochemically modified amyloid-β (Aβ) in the brain of subjects with Alzheimer’s disease (AD) has been suggested to be of significance for cognitive impairment. Our previous reports have shown that Aβ is observed in 63% of all subjects with idiopathic normal pressure hydrocephalus (iNPH) suggesting that the majority of iNPH subjects with Aβ are indeed also suffering from AD. Objective: We assessed the occurrence of biochemically modified Aβ variants, in vivo, in subjects with iNPH and in a cohort of postmortem brain samples from patients with dementia. Methods: We assessed Aβ proteins in 127 diagnostic brain biopsies obtained from subjects with iNPH and in a cohort of subjects with dementia by means of immunohistochemistry. Results: The pyroglutamylated Aβ (pyAβ) precedes the aggregation of phosphorylated Aβ (pAβ) during the AD neuropathological change progression; moreover, these modified variants of Aβ correlate with hyperphosphorylated tau in the frontal cortical area of human brain. Our results confirm the existence of the suggested biochemical stages of Aβ aggregation that might be of significance for neurodegeneration leading to cognitive impairment. Conclusion: The observation that both pyAβ and pAβ are seen in vivo in iNPH subjects is intriguing. It has been reported that most of the iNPH subjects with Aβ in the brain biopsy indeed develop AD with time. Based on our current and previous results, it is clinically merited to obtain a diagnostic biopsy from a subject with iNPH. When Aβ is observed in the biopsy, the biochemical characterization is of interest.


2012 ◽  
Author(s):  
William J. Burns ◽  
August E. Shapiro ◽  
Yvonne Demsky ◽  
Kayreen A. Burns

Sign in / Sign up

Export Citation Format

Share Document